Xumei
Ouyang
abc,
Xiaoling
Wang
ab,
Heinz-Bernhard
Kraatz
d,
Soha
Ahmadi
d,
Jianqing
Gao
c,
Yuanyuan
Lv
a,
Xiaoyi
Sun
*a and
Yongzhuo
Huang
*e
aDepartment of Pharmacy, Zhejiang University City College, Hangzhou 310015, China. E-mail: sunxiaoyi@zucc.edu.cn; Tel: +86-571-88284325
bDepartment of Pharmacy, School of Ophthalmology & Optometry and Eye Hospital, Wenzhou Medical University, Wenzhou, 325035, China
cDepartment of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
dDepartment of Physical and Environmental Sciences, University of Toronto Scarborough, Toronto, ON M1C 1A4, Canada
eState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Rd, Shanghai, 201203, China. E-mail: yzhuang@simm.ac.cn; Tel: +86-21-20231981
First published on 14th January 2020
Correction for ‘A Trojan horse biomimetic delivery strategy using mesenchymal stem cells for PDT/PTT therapy against lung melanoma metastasis’ by Xumei Ouyang et al., Biomater. Sci., 2020, DOI: 10.1039/c9bm01401b.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2020 |